주식/증권
📉 부정적
3 Reasons TNDM is Risky and 1 Stock to Buy Instead
요약
Over the last six months, Tandem Diabetes’s shares have sunk to $22.45, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 10.5% gain. This might have investors contemplating their next move.